![](/img/cover-not-exists.png)
O-085 Phase III trial of the protein kinase C α (PKCα) antisense oligonucleotide Aprinocarsen plus gemcitabine/cisplatin versus gemcitabine/cisplatin alone in advanced stage non-small cell lung cancer (NSCLC): Updated results of a randomized phase III trial
Gandara, D., Douillard, J., Koralewski, P., Manegold, C., Smit, E., Reyes, J., Chang, G., Obasaju, C., Peterson, P., Paz-Ares, L.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80218-1
Date:
July, 2005
File:
PDF, 151 KB
english, 2005